Tools

LEADER 03790cam 22005177i 4500

001 ssj0001722267;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 170316s2016 dcua sb 000 0 eng d;

010 a| 2017303136;

020 a| 9780309437998 (pbk);

020 a| 0309437997 (pbk0;

035 a| (WaSeSS)ssj0001722267;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RC848.H44b| N38 2016;

082 04 a| 614.5936232| 23;

110 2 a| National Academies of Sciences, Engineering, and Medicine (U.S.).b| Committee on a National Strategy for the Elimination of Hepatitis B and C.=| ^A1331681;

245 10 a| Eliminating the public health problem of hepatitis B and C in the United Statesh| [electronic resource] :b| phase one report /c| Gillian J. Buckley and Brian L. Strom, editors ; Committee on a National Strategy for the Elimination of Hepatitis B and C, Board on Publication Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.;

260 a| Washington, DC :b| the National Academies Press,c| [2016];

300 a| xiv, 171 pages :b| color illustrations ;c| 23 cm;

504 a| Includes bibliographical references.;

506 a| Available only to authorized users.;

520 1 a| "Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report"--c| Publisher's description.;

538 a| Mode of access: World Wide Web;

650 0 a| Hepatitis Bz| United Statesx| Prevention.=| ^A849132;

650 0 a| Hepatitis Cz| United Statesx| Prevention.=| ^A272854;

650 7 a| Hepatitis Bx| Prevention.2| fast0| (OCoLC)fst00955203;

650 7 a| Hepatitis Cx| Prevention.2| fast0| (OCoLC)fst00955215;

651 7 a| United States.2| fast0| (OCoLC)fst01204155?| UNAUTHORIZED;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Buckley, Gillian J.=| ^A1333772;

700 1 a| Strom, Brian L.=| ^A804576;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=4558366;

947 a| (OCoLC)ocn953096328;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5645171;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5645171-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 7/19/2021x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5645171-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 7/19/2021x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5645171-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 7/19/2021x| EBOOKz| JERESOURCE;

Eliminating the public health problem of hepatitis B and C in the United States phase one report / Gillian J. Buckley and Brian L. Strom, editors ; Committee on a National Strategy for the Elimination of Hepatitis B and C, Board on Publication Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.

Author/creator	National Academies of Sciences, Engineering, and Medicine (U.S.).
Other author	Buckley, Gillian J.
Other author	Strom, Brian L.
Format	Electronic
Publication Info	Washington, DC : the National Academies Press, [2016]
Description	xiv, 171 pages : color illustrations ; 23 cm
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Hepatitis B--United States. --Prevention. Hepatitis C--United States. --Prevention.

Review	"Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report"-- Publisher's description.
Bibliography note	Includes bibliographical references.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2017303136
ISBN	9780309437998 (pbk)
ISBN	0309437997 (pbk0

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability